Aurora Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Dive Deeper Into the Activities Behind the Analysis
This Aurora Value Chain Analysis gives you a structured view of how Aurora creates value across its support and primary activities. This page already shows a real preview of the analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
Aurora Cannabis Inc. relies on a compliance-heavy firm infrastructure to manage Canadian and international licensing, financial controls, and quality oversight across its FY2025 reporting cycle ended March 31, 2025. That structure helps coordinate production, reporting, and market access across medical and adult-use channels while supporting regulated operations in multiple jurisdictions. In a sector where one missed control can slow shipments or trigger license risk, this back-office layer is a core value-chain enabler, not just overhead.
Human Resource Management
Aurora Cannabis Inc. relies on growers, extraction staff, quality specialists, and regulatory talent to keep its licensed cannabis operations running. In fiscal 2025, Aurora Cannabis Inc. reported net revenue of C$343.4 million and gross margin before fair value changes of 57%, so skilled hiring and training directly support product consistency and compliance. With operations spanning medical and international channels, HR management helps reduce error, keep licenses in good standing, and protect output quality.
Technology Development
Aurora Cannabis Inc. uses research and product development to improve cultivation, extraction, and formulation methods, which helps launch new cannabis-derived products and sharpen medical and adult-use differentiation. In fiscal 2025, that work sat inside a business that reported annual net revenue in the hundreds of millions of Canadian dollars, so even small gains in yield, potency, or processing speed can move margins. Technology development also supports better extraction consistency and faster product iteration, which matters in regulated markets where quality and compliance drive repeat demand.
Procurement
Aurora Cannabis Inc. uses procurement for cultivation inputs, packaging, lab supplies, and distribution services. In fiscal 2025, Aurora Cannabis Inc. reported net revenue of C$300.6 million, so buying power and supplier control matter in a margin-tight setup.
Careful sourcing helps keep product quality consistent, protect regulated inventory, and limit waste or stock-outs. It also supports cost control when each input cost can move gross margin fast.
Aurora Cannabis FY2025: Back-Office Discipline Protected Growth
Aurora Cannabis Inc.'s support activities in FY2025 centered on compliance, skilled labor, R&D, and sourcing. With net revenue of C$343.4 million and gross margin before fair value changes of 57%, these back-office functions helped protect quality, control costs, and keep licenses and supply lines working across regulated markets.
| FY2025 metric | Value |
|---|---|
| Net revenue | C$343.4M |
| Gross margin before FV changes | 57% |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Aurora Cannabis Inc. uses controlled, traceable intake for genetics, grow inputs, packaging, and lab materials; in fiscal 2025, net revenue was C$343.4 million, so supply flow matters. Tight receiving checks support quality, stock accuracy, and GMP compliance before cultivation and processing. That lowers spoilage risk and keeps regulated production on schedule.
Operations
Aurora Cannabis Inc. adds value by cultivating, harvesting, drying, processing, extracting, formulating, and packaging cannabis biomass into dried flower, oils, edibles, and concentrates for medical and adult-use markets.
In fiscal 2025, Aurora Cannabis Inc. reported net revenue of about C$310 million, showing this production chain is tied to real sales, not just output.
Its operations matter because each step shapes potency, consistency, shelf life, and yield, which directly affects margin and product quality.
Outbound Logistics
Aurora Cannabis Inc. ships finished products through licensed channels to pharmacies, medical clinics, and retail stores, so outbound logistics must stay tight on order accuracy and traceability. In fiscal 2025, Aurora Cannabis Inc. reported net revenue of about C$343 million, and that scale makes compliant fulfillment a real profit driver. For domestic and international delivery, each batch needs tracking from release to receipt to meet cannabis rules and protect margins.
Marketing and Sales
Aurora Cannabis Inc. uses medical and adult-use channels to sell, but marketing leans on medical trust, brand building, and product education. In fiscal 2025, Aurora Cannabis Inc. reported net revenue of CA$262.1 million, with market access still tied to channel partners and physician and patient awareness.
Credible product claims matter because adult-use is crowded and medical buyers need proof on quality, dose, and consistency. Strong sales performance depends on keeping shelf space, winning prescriptions, and turning awareness into repeat orders.
Service
Aurora Cannabis Inc. uses service to give product guidance, quality follow-up, and issue resolution after sale, which matters in a regulated market where trust drives repeat orders. In fiscal 2025, Aurora Cannabis Inc. reported net revenue of C$343.7 million, so post-sale support helps protect that base. Fast responses also matter for medical buyers and retailers, since a small service miss can hurt compliance confidence and demand.
Aurora Cannabis's Revenue Depends on Cultivation, Quality, and Compliance
Aurora Cannabis Inc. primary activities start with controlled sourcing and cultivation; fiscal 2025 net revenue was C$343.4 million, so input control and grow quality directly affect sales.
It then processes, formulates, and packages cannabis into dried flower, oils, and concentrates, where yield, potency, and shelf life drive margin.
Finished goods move through licensed channels, so traceability, order accuracy, and compliant delivery are core to revenue.
| Fiscal 2025 | Value |
|---|---|
| Net revenue | C$343.4 million |
| Primary focus | Cultivate, process, package |
Preview the Actual Deliverable
Aurora Reference Sources
You're previewing the actual Aurora Value Chain Analysis document, not a sample. The preview shown here is the same file the customer will receive after purchase. Once checkout is complete, the full Value Chain Analysis becomes available immediately. No surprises – just the complete, professional document.
Frequently Asked Questions
Aurora Cannabis Inc.'s value chain is driven most by operations and compliance. The business serves 2 markets, medical and adult-use, and sells through 3 channel types: pharmacies, medical clinics, and retail stores. That makes cultivation yield, processing consistency, and regulated distribution the main value drivers.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.